Interní Med. 2011; 13(12): 493-495

Polymyalgia rheumatica as a cause of chronic polyarthralgias

MUDr.Andrea Smržová1, prof.MUDr.Pavel Horák, CSc.1, MUDr.Martina Skácelová1, MUDr.Eva Buriánková2, MUDr.Lenka Henzlová2
1 III. interní klinika &ndash, nefrologická, revmatologická a endokrinologická, FN a UP Olomouc
2 Klinika nukleární medicíny FN a UP Olomouc

Polymyalgia rheumatica (PR) is linked to giant-cell arteritis in up to thirty percent of cases, which is also the case of the present case

report of an elderly woman with chronic polyarthralgias and high inflammatory markers. A broad differential diagnostic spectrum of

these conditions and advantages of the PET/CT examination are highlighted.

Keywords: polymyalgia rheumatica, giant-cell vasculitis, temporal arteritis, FDG PET/CT

Published: December 18, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Smržová A, Horák P, Skácelová M, Buriánková E, Henzlová L. Polymyalgia rheumatica as a cause of chronic polyarthralgias. Interní Med. 2011;13(12):493-495.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gonzalez-Gay MA, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009; 61: 1454. Go to original source... Go to PubMed...
    2. Dasgupta B, et al. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol. 2008; 35: 270-277. Go to PubMed...
    3. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372: 234. Go to original source... Go to PubMed...
    4. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995; 122(7): 502. Go to original source... Go to PubMed...
    5. Hernández-Rodríguez J, Cid MC, López-Soto A, et al. Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med 2009; 169: 1839. Go to original source... Go to PubMed...
    6. Dejaco C, et al. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2011; 70(3): 447-453. Go to original source... Go to PubMed...
    7. Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology 1993; 100(4): 550. Go to original source... Go to PubMed...
    8. García-Martínez A, et al. Development of aortic aneurysm/ dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum. 2008; 59(3): 422. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.